Flexion Therapeutics, Inc. — Net Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6e093cf9-0aeb-42db-9ff2-631cd5fcc73a/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-113.7M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-012050 |
| FY 2019 | $-149.8M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-010490 |
| FY 2018 | $-169.7M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-005465 |
| FY 2017 | $-137.5M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-004912 |
| FY 2016 | $-71.9M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-016569 |
| FY 2015 | $-46.3M | 2015-01-01 – 2015-12-31 | evidence 0001564590-17-016569 |
| FY 2014 | $-27.3M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-103253 |
| FY 2013 | $-72.7M | 2007-11-06 – 2014-03-31 | evidence 0001193125-14-194852 |
| FY 2012 | $-15.0M | 2012-01-01 – 2012-12-31 | evidence 0001193125-14-194852 |
| FY 2011 | $-11.4M | 2011-01-01 – 2011-12-31 | evidence 0001193125-14-194852 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Flexion Therapeutics, Inc. — all facts · Revenue · Operating Income